NobleOak Life Limited (NOL.AX)
AUD 1.66
(0.91%)
AUD 1.66
(0.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 15.55 Million AUD | -16.68% |
| 2023 | 18.67 Million AUD | -170.81% |
| 2022 | 4.21 Million AUD | 309.86% |
| 2021 | 8.51 Million AUD | -1477.78% |
| 2020 | 11.96 Million AUD | -118.0% |
| 2019 | 700 Thousand AUD | 70000100.0% |
| 2018 | 4.53 Million AUD | 99.67% |
| 2017 | 2.96 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1 Million AUD | 91.75% |
| 2024 Q3 | 1.81 Million AUD | 81.45% |
| 2024 FY | - AUD | 168.31% |
| 2024 Q4 | 1.01 Million AUD | -43.9% |
| 2024 Q1 | - AUD | -91.13% |
| 2023 Q2 | -441.5 Thousand AUD | 0.0% |
| 2023 Q3 | -1.03 Million AUD | -134.54% |
| 2023 FY | - AUD | -170.81% |
| 2023 Q1 | -441.5 Thousand AUD | -910.09% |
| 2023 Q4 | -1.03 Million AUD | 0.0% |
| 2022 Q4 | 54.5 Thousand AUD | 0.0% |
| 2022 Q3 | 54.5 Thousand AUD | 103.84% |
| 2022 Q2 | -1.41 Million AUD | 0.0% |
| 2022 FY | - AUD | 309.86% |
| 2022 Q1 | -1.41 Million AUD | -46.26% |
| 2021 Q1 | -24.5 Thousand AUD | 15.52% |
| 2021 FY | - AUD | -1477.78% |
| 2021 Q4 | -969.5 Thousand AUD | 0.0% |
| 2021 Q3 | -969.5 Thousand AUD | -3857.14% |
| 2021 Q2 | -24.5 Thousand AUD | 0.0% |
| 2020 Q2 | -34 Thousand AUD | 0.0% |
| 2020 Q1 | -34 Thousand AUD | 0.0% |
| 2020 FY | - AUD | -118.0% |
| 2020 Q4 | -29 Thousand AUD | 0.0% |
| 2020 Q3 | -29 Thousand AUD | 14.71% |
| 2019 FY | - AUD | 70000100.0% |
| 2018 FY | - AUD | 99.67% |
| 2017 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Challenger Limited | 938.5 Million AUD | 98.342% |